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OBJECTIVE: To identify the best mode for diagnosing and treating the patients with choledochal cysts.
METHODS: A retrospective study was performed with medical records of patients diagnosed with choledochal
cysts from January 1994 to December 2017. In all cases, the diagnosis was based on ultrasound examination.
All the patients underwent cyst resection and were divided in two groups: bile enteric anastomosis in the high
portion of the common hepatic duct or in the dilated lower portion.
RESULTS: Eighty-one cases were studied. The age of presentation was 4 y 2 mo± 4 y 1 mo, and the age for the
surgical treatment was 5 y 5 mo± 4 y 6 mo. In 61 cases, US was the only image examination performed. There
were 67 cases of Todani type I (82.7%), 13 cases of type IV (16.0%) and one case of type III (1.2%). Nine patients
(29.0%) in the first period and 2 patients (4.0%) in the second period presented with postoperative
complications (p=0.016).
CONCLUSION: In patients with choledochal cysts, US is the only necessary diagnostic imaging. Performing the
bile enteric anastomosis in the lower portion of the common hepatic duct is safer and has a lower risk of
complications.
KEYWORDS: Choledochal Cyst; Pancreaticobiliary Maljunction; Pancreatitis; Congenital Biliary Dilatation;
Hepaticojejunostomy.
’ INTRODUCTION
Choledochal cyst, or congenital bile duct dilatation, is a rare
pathology, with a higher incidence in the Far East (1,2). It was
first described in 1723 by Vater and Ezler and has a predis-
position to develop into cholangiocarcinoma in adult life. The
etiology is not completely understood; however, the most
accepted hypothesis states its association with an anomalous
pancreaticobiliary junction (APBDJ), which causes pancreatic
secretion reflux into the biliary ducts, causing inflammation
and duct dilatation. In some studies, the prevalence of APBDJ
association with choledochal cysts is 97% (3-6).
It is believed that a well performed ultrasonography (US) is
the only imaging exam necessary for diagnosis prior to surgery.
Other types of imaging may assist in surgical planning, but
they do not change the final management of the disease.
Cyst excision and biliodigestive reconstruction by hepati-
coduodenostomy or hepaticojejunostomy with Roux-en-Y
are the preferred methods to manage the disease in order to
resolve biliary obstruction and eliminate the possibility of
malignization of the dilated portion of the biliary duct (7-11).
However, performing biliodigestive anastomosis in a lower
portion of the common hepatic duct, where the diameter is
wider, facilitates the surgical procedure and likely reduces
the occurrence of postoperative complications.
Currently, with the modern imaging methods for diagnos-
ing biliary diseases, as well as the different types of surgical
treatments for these pathologies, there is no recent study that
defines the best mode for diagnosing and treating patients
with choledochal cysts. Therefore, these are the main objec-
tives of the current study based on the experience of patients
in a period of 24 years treated in a tertiary surgical university
pediatric center, which has additional experience in liver
transplantation.
’ MATERIALS AND METHODS
A retrospective study was performed with medical records
from São Paulo University Medical School Children’s
Institute from January 1994 to December 2017. Our research
included gender, symptoms at presentation, age, medical
imaging, type of dilatation (following the Todani’s classifica-
tion (12)), performed surgery, complications and survival for
all the patients. The study protocol was approved by the
ethical Committee of our Institution.DOI: 10.6061/clinics/2020/e1539
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In our service, most choledochal cyst cases were referred
from primary or secondary care public medical services. Some
cases were referred to our institution with prior imaging
exams, such as US, magnetic resonance cholangiopancreato-
graphy (MRCP) or computed tomography (CT). In these
cases, US was repeated under our care, and if the diagnosis
was confirmed, surgery was recommended for the patient.
In cases without imaging before referral, an US examina-
tion was done and surgery was performed without additi-
onal imaging (Figure 1). As a tertiary care center, we have an
experienced team of radiologists able to perform US exami-
nation in children’s biliary trees. For the statistical analysis,
we only considered imaging that was performed in our
institution.
Surgery was performed in our institution using two
methods. The senior surgeons (UT and ACAT) participated
in all surgeries. The patients were divided into two groups
according to the period and procedure. During the period
of January 1994 to December 2005 (first period), a biliary
reconstruction through hepaticojejunostomy Roux-en-Y was
done. The anastomosis was performed in the higher portion
of the common hepatic duct, leaving a narrower common
hepatic duct diameter for suturing. During the period of
January 2006 to December 2017 (second period), we perfor-
med a lower anastomosis at the common hepatic duct,
leaving a small dilated portion of the common hepatic duct
and permitting an easier anastomosis (Figure 2). In both
cases, anastomosis was made with a 5.0 or 6.0 vicryl suture
line, with interrupted sutures.
When it was not possible to completely excise the cyst
mucosa due to adherence to another structure, such as the
pancreas parenchyma, inferior vena cava or hepatic hilar
vessels, Lilly’s technique was used. This technique consists
of mucosal excision through cauterization, while the serosa
remains attached to the adhering structures (13). Postoperative
complications were studied and graded by the Clavien-
Dindo classification (14). The follow-up periods varied from
18 months to 19 years.
Statistical analysis
Numerical data were presented as the mean ± standard
deviation, and categorical data were presented as frequencies
and percentages. A chi-square test was applied to compare
the complication frequency in the two periods of time.
Statistical analysis was made using R-Commander software
though R programming language. A p-value was considered
significant if po0.05.
Figure 1 - US image of choledochal cyst. Note that no other examination is necessary for surgery planning.
Figure 2 - Final aspect after resection of the choledochal cyst.
Note the small dilated portion of the common hepatic duct and
the orifices of both hepatic ducts.
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’ RESULTS
Eighty-one cases of choledochal cysts were found in our
institution during the period of study. Fifty-seven patients
(70.3%) were female and 24 (29.7%) were male.
The age of presentation was 4 y 2 mo± 4 y 1 mo, and the
age for the surgical treatment was 5 y 5 mo ± 4 y 6 mo,
ranging from 3 days to 21 years. The most prevalent symp-
toms are presented in Table 1. The classic triad of the disease
(jaundice, abdominal pain and palpable abdominal mass) was
present in 3 cases (3.7%). The presence of at least two of the
three classic symptoms was observed in 30 cases (37.0%).
Regarding the Todani’s classification, sixty-seven were
type I (82.7%), thirteen were type IV (16.0%) and one was
type III (1.2%).
The diagnosis was initially made by ultrasonography in all
cases. In 61 cases, this was the only imaging examination
performed (75.3%). To confirm the diagnosis, CTwas perfor-
med, along with US, in an additional 20 cases (24.7%), and
MRCP was also performed in 2 cases (2.5%). Three diagnoses
(3.7%) were made by antenatal US.
In the first phase of study, an endoscopic cholangiopan-
creatography (ECPG) examination was used for diagnostic
investigation in 7 cases (8.6%); it was diagnosed as an ano-
malous pancreatic biliary duct junction in 5 cases). Choles-
cintigraphy was used in one case (1.2%), associated with US
and CT.
There were no false negative or false positive results in
ultrasonography imaging in our study. In all 20 cases, the
diagnosis of choledochal cysts made by US was confirmed
by CT or other imaging techniques. Endoscopic cholangio-
pancreatography confirmed the diagnosis of the only case of
type III choledochal cysts diagnosed by US. Finally, all US
diagnoses were confirmed by the operatory findings.
Among the 31 patients in the first period, 9 of them (29.0%)
presented with major morbidity postoperative complica-
tions, characterized by Clavien Dindo Grade III and above:
four cases of late biliary stenosis (12.9%), three cases of
biliary fistula (9.7%), one case of cholangitis (3.1%), one case
(3.1%) of abdominal wall infection, and two deaths (6.2%)
due to postoperative biliary anastomosis dehiscence and
sepsis. In the second period, 50 patients were operated on
with 2 complications (4.0%): one case (2.0%) of anastomotic
dehiscence that was successfully corrected by reoperation
and one case (2.0%) of abdominal wall infection. Among all
patients of both periods, Lilly’s maneuver was used in 6
cases (7.4%). The only patient with a Todani type III cyst was
treated through sphincterotomy by ECPG. All the patients
with biliary stenosis had to undergo reoperation of the
biliary anastomosis. Three of them remained with percuta-
neous dilatation of the biliary tree, although the liver function
tests were normal. The incidence of complications was
statistically lower in the second period (p=0.016).
In the late follow up, one patient of each period had to
be submitted to liver transplantation due to the development
of cirrhosis and hepatic insufficiency, even with adequate
biliary reconstruction. Presently, both patients are doing well.
Finally, no patient presented with cancer of biliary tract.
’ DISCUSSION
With regards to a large series of cases of choledochal cysts
in children treated in a single reference center of pediatric
liver diseases and liver transplantation, some points must be
discussed.
Etiology: The etiology of the choledochal cysts is not well
understood. There are many theories that try to explain its
pathophysiology. The most accepted theory for choledochal
cysts is Babbitt’s theory, which proposes a cause and effect
correlation between an anomalous pancreaticobiliary ductal
junction (APBDJ) and choledochal cysts (15). The association
between APBDJ and choledochal cysts ranges from 57% to
96% (16), and some studies have identified APBJD as a bad
prognostic factor (17,18).
The proposed cause for the association between choledo-
chal cysts and APBDJ is the reflux of pancreatic secretions to
the biliary tree, resulting in activation of proteolytic enzymes,
which are responsible for inflammation and weakening of the
common bile duct wall (19). In addition, it was verified that
there is a reduction of ganglion cells in choledochal cysts wall,
indicating the possibility of dilatation of the common bile duct
as a result of functional obstruction (20).
In the current study, we propose that cholangiography
by endoscopy in order to determine if the patient has an
associated APBDJ is not necessary, since it would not modify
the surgical procedure. We can verify that the majority of
cases (82.7%) were included in the Todani type 1 classifica-
tion, which corresponds to a fusiform dilatation of the
common bile duct, followed by 16.0% of cases with Todani
type IV, which is defined as cystic dilatation of extrahepatic
biliary ducts (associated or not with intrahepatic ducts
dilatation). This observation is similar to other published
series in literature (21,22).
Gender: In the current series, we verified the predilection
for females (2.3 females to 1 male), similar to other previous
studies, which vary from 1.6:1 to 3.7:1 (22-24). The mean ages
of symptom onset and surgical treatment were comparable
to those reported in other studies (19-22), although we have
verified that the diagnosis has been made earlier due to the
wide use of ultrasound examination in children with non-
specific abdominal pain. Regarding the type of symptoms,
we found only three cases with the classic triad, which is less
than those reported in the literature at 6 to 13% (23,25,26). We
also saw the presence of 2 of the 3 symptoms of the triad in
28 patients (34.6%), which is less than those reported in other
series at 66 to 85% (27,28). Again, we think this difference is
due to the wide utilization of ultrasound examination.
Imaging: In our service, US was used in all cases as a
diagnostic tool, being the only medical imaging tool in 61
cases. Due to its low cost and high availability, US constitutes
the most important imaging exam for choledochal cyst
investigation (29,30). We advise that US is the only necessary
imaging for surgery. Other exams, such as MRCP, TC, ERCP
or cholangiography do not change the therapeutic decision
(cyst excision with Roux-en-Y hepaticojejunostomy).
Table 1 - Symptoms presented by the patients with choledochal
cyst.
Symptom Number of patients (%)
abdominal pain 48 (59.2%)
jaundice 45 (55.5%)
episodes of pancreatitis 13 (16.0%)
palpable abdominal mass 13 (16.0%)
vomits 12 (14.8%)
fecal acholia 8 (9.9%)
choluria 8 (9.9%)
asymptomatic 5 (6.2%)
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Classically, MRCP has been considered the gold standard
imaging method for the diagnosis of choledochal cysts (16).
A comparative study between MRCP and CTwith 14 patients
subjected to both diagnostic tools demonstrated that MRCP
has a better sensibility compared to CT (100% to 90.9%) (31).
However, we may consider that, currently, US examination
can provide an accurate diagnosis of all details in a child with
choledochal cysts, including the visualization of the intrahe-
patic biliary tree. MRCP has the disadvantage of the necessity
of general anesthesia in many children. In addition, it is
important to stress that CT may be avoided in children due to
nephron and hepatotoxicity produced by the utilized contrast,
along with radiation exposure. Therefore, we have elected the
US examination as the gold standard examination method for
the diagnosis of choledochal cysts in children. The only
disadvantage of the US examination is that it cannot precisely
diagnose the existence of a concomitant APBDJ. However, this
diagnosis does not change the management of the disease,
since Roux-en-Y biliary reconstruction should be performed
independently of its existence.
Prenatal diagnosis through ultrasonography was per-
formed in three patients in the current series. Antenatal US
can make the correct diagnosis in up to 15% of choledochal
cyst cases (32), even though it cannot differentiate choledochal
cysts from biliary atresia in a majority of cases. The impor-
tance of this finding is that it indicates an early laparotomy,
with known advantages in cases of biliary atresia.
Treatment: The treatment of choice in our institution during
the first period of study was a high anastomosis through
Roux-en-Y hepaticojejunostomy anastomosis. In 2006, we
decided to perform a lower hepaticojejunostomy anastomosis,
maintaining a wider portion of the common hepatic duct, in
order to technically facilitate the anastomosis and prevent
postoperative complications. We performed this procedure
even in the presence of a dilated common hepatic duct,
despite previous recommendations from Japan to perform the
anastomosis as high as possible in the hepatic duct (33,34).
The risk of biliary cancer after a Roux-en-Y hepaticojeju-
nostomy is controversial. It is known that the cystic dila-
tations have a greater possibility of malignization (Todani
cysts type I and IV), so its complete excision is advised
(33,34). The risk of malignization after cyst excision is 0.7% to
5.4% (33,35,36). In addition, there are reports about malig-
nization of the remaining intrapancreatic portion of the
common bile duct when it is not excised (37-39). However,
there is no reported risk of malignization in the fusiform
dilation of the hepatic duct.
It is important to report the interesting study of Ishibashi
et al. who followed up 28 patients with incomplete chole-
dochal cyst excision and reported no cases of malignancy
(40). These authors argue that biliary cancer after Roux-en-Y
hepaticojejunostomy may be due to remaining cells of an
already existing carcinoma in the dilated part of the biliary
tract rather than de novo carcinoma formed after excision. In
other words, the postoperative risk of biliary cancer deve-
lopment is biased in many studies due to an already existing
carcinoma that was not detected prior to or during surgery.
In another study that included 39 patients with both APBDJ
and choledochal cysts, it was found a correlation between
age and biliary metaplasia, which could justify the deve-
lopment of biliary tract cancer (41). With this in mind, we
may suggest that the hepaticojejunal anastomosis should
be facilitated by leaving a portion of the dilated common
hepatic duct after cyst excision if the cyst cannot be excised
with a satisfactory portion of the common bile duct for
anastomosis.
In pediatric patients, as in our case, the chance of an
already existing cancer or metaplasia of the biliary mucosa is
minimal. Therefore, the risk of biliary cancer after cyst
excision is probably negligible in children, even in the long
term. This allows us to use part of the cyst to facilitate the
anastomosis in order to provide a safer surgery, even with
the possible risk of developing biliary cancer.
Finally, the discussion about the technique of biliary
reconstruction with hepaticojejunostomy or hepaticoduode-
nostomy is not significant. It is clear that the occurrence of
duodenogastric bile reflux and reflux of duodenum content
to the biliary tree observed in cases of hepaticoduodenost-
omy is a clear disadvantage of this technique. (42-44)
Complete cyst excision of Todani I and IV cysts is not always
achievable, especially when the cyst is near an important
structure, such as the vena cava. In this case, Lilly’s tech-
nique may be utilized, as we performed in 7 cases (8.6%).
This procedure definitely prevents injury of the pancreas
or the vena cava, as well as future malignization of the
remaining mucosa.
The only case of Todani type III, also known as choledo-
chocele, was subjected to ERCP sphincterotomy without
mucosa excision. It is recognized that this type of choledo-
chal cyst has a lower probability of malignization, which has
led many centers to recommend endoscopic or surgical
treatment without mucosal excision, although some centers
recommend cyst excision through duodenostomy (16,45-50).
In fact, there are few studies following patients with choledo-
chocele submitted to ERCP sphincterotomy. In a study from
Japan, 3 of 11 patients with choledochocele developed
periampullary carcinoma, which indicates that malignization
is not as rare as first thought and suggests that a disjunction
of the biliary and pancreatic systems though Roux-en-Y
biliary reconstruction should be the standard treatment for
all choledochal cyst types (51).
Complications: Twelve patients had major postoperative
complications and morbidities, characterized by Clavien
Dindo Grade III and above. This incidence of postoperative
complications and mortality was similar to other published
series (52). However, if we consider the two periods of
study, we had a lower incidence of complications in the
second period, when the hepatic jejunal anastomosis was
performed in the lower portion of the common hepatic duct
(p=0.016). This important conclusion is clear evidence that
we must perform the biliary anastomosis according to this
principle, and we must avoid anastomoses in the high por-
tion of common hepatic duct, where the diameter is usually
narrower.
Finally, two patients had to undergo liver transplantation
in the late follow up, even with adequate biliary reconstruc-
tion. In these patients, biliary cirrhosis was not alleviated by
adequate bile drainage, which progressed to hepatic insuffi-
ciency. Therefore, liver transplantation was necessary, des-
pite the literature evidence of biliary cirrhosis regression after
surgical treatment.
In conclusion, the current study shows that for the patients
with choledochal cysts, US is the only necessary diagnostic
imaging required for the final diagnosis and surgical
planning. The bile-enteric anastomosis must be performed
in the dilated lower portion of the common hepatic duct in
order to guarantee a safe anastomosis and reduce the risks
of postoperative complications.
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